-transparent.png){kind=logo}
Serum vitamin D metabolites, the renal tubular maximum reabsorptive rate for phosphate (TMP/GFR) nephrogenic cyclic AMP (NcAMPI, and CaE (urinary calcium excretion per litre of glomerular filtrate) were measured in 14 adults with familial hypocalciuric hypercalcaemia (FHH). The findings were compared with analyses in 14 patients with surgically proven primary hyperparathyroidism matched for serum calcium, creatinine clearance and vitamin D status (assessed by serum concentrations of 25 hydroxyvitamin D). Vitamin D metabolites were also measured in 16 normocalcaemic relatives of patients with FHH. The serum concentration of 24,25 dihydroxycholecalciferol was appropriate for the prevailing 25 hydroxyvitamin D and no difference was found between groups. The serum concentration of 1,25 dihydroxycholecalciferol was significantly greater in primary hyperparathyroidism (P less than 0.0005) compared with patients with FHH and their normocalcaemic relatives. TMP/GFR was reduced in both primary hyperparathyroidism (0.53 +/- 0.12 mmol/l GF, mean +/- SEM) and FHH (0.86 +/- 0.14 mmol/l GF). Patients with primary hyperparathyroidism showed an increase in NcAMP output in the urine (38.5 +/- 16 mmol/l GF) which was significantly greater (P less than 0.0001) than the normal NcAMP (13.5 +/- 9.2 nmol/l GF) found in FHH. CaE was low in FHH indicating increased renal tubular reabsorption of calcium. It is concluded that there is no abnormality of vitamin D metabolism in FHH comparable with the changes observed in primary hyperparathyroidism. It is suggested that the biochemical abnormalities in FHH cannot be explained solely upon an increased sensitivity of the renal tubules to the effects of endogenous parathyroid hormone.
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
November 1985,
Clinical endocrinology,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
September 1984,
Clinical endocrinology,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
February 1982,
Lancet (London, England),
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
August 1992,
Danish medical bulletin,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
June 1987,
Clinical endocrinology,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
October 2014,
BMJ case reports,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
February 2011,
Scottish medical journal,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
October 1987,
Postgraduate medical journal,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
June 1984,
Acta endocrinologica,
M Davies, and
P H Adams, and
J L Berry, and
G A Lumb, and
P S Klimiuk, and
E B Mawer, and
D Wain
July 2009,
European journal of endocrinology,
